ACRO BIOMEDICAL CO., LTD. Operating Loss Carryforwards
ACRO BIOMEDICAL CO., LTD. (ACBM) had Operating Loss Carryforwards of $33.00 million as of 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2026-02-11
- 2025-12-31: Operating Loss Carryforwards $33.00M.
- 2024-12-31: Operating Loss Carryforwards $33.00M.
- 2023-12-31: Operating Loss Carryforwards $33.00M.
- 2022-12-31: Operating Loss Carryforwards $24.00M.
| Period end | Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $33.00M 10-K · filed 2026-02-11 |
| 2024-12-31 | $33.00M 10-K · filed 2025-07-24 |
| 2023-12-31 | $33.00M 10-K · filed 2025-07-18 |
| 2022-12-31 | $24.00M 10-K · filed 2023-07-21 |
| 2021-12-31 | $8.03M 10-K · filed 2022-04-15 |
| 2020-12-31 | $317.00K 10-K · filed 2021-04-02 |
| 2019-12-31 | $186.90K 10-KT · filed 2020-03-27 |
| 2019-09-30 | $111.00K 10-K · filed 2020-01-07 |
| 2019-06-30 | $47.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $310.00K 10-Q · filed 2019-05-15 |
| 2017-12-31 | $14.01K 10-Q · filed 2018-02-14 |
| 2017-09-30 | $94.24K 10-Q · filed 2018-02-14 |